ReviewHerzschrittmachertherapie & Elektrophysiologie2026
[Risk of stroke during left atrial catheter ablation for atrial fibrillation].
Review in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periprocedural stroke is one of the most relevant complications of left atrial catheter ablation for atrial fibrillation. Procedure-specific and patient-specific factors as well as the experience of the interventionalists and the intervening center are relevant for the risk of periprocedural stroke. In recent years, the risk of periprocedural stroke has been reduced to less than 0.5% in specialized centers, due to technical advances and the interdisciplinary implementation of magnetic resonance imaging (MRI)-based studies on the risk of procedure-associated cerebral embolism. In addition to appropriate awareness, a standard operating procedure (SOP) is particularly important for the treatment of periprocedural and postprocedural stroke. The SOP should include preventive strategies to avoid stroke, periprocedural blood pressure management, peri- and postprocedural anticoagulation and potential antagonists in cases of (intracranial) bleeding. Furthermore, the SOP should outline further intrahospital treatment pathways. In the event of acute ischemic stroke the possibility of systemic thrombolysis should be evaluated within 4.5 h of symptom onset in cases of a clinically relevant neurological deficit, based on an individual risk-benefit assessment and taking present guideline recommendations as well as product-specific information provided by the manufacturer into account. If an acute proximal occlusion of a brain-supplying artery as well as corresponding clinical symptoms are present, catheter-based ("mechanical") recanalization is indicated within a time window of up to 24 h after (possible) onset of symptoms as this can be performed independently of anticoagulant medication. Notably, no randomized studies on the efficacy and safety of these treatments aimed at recanalization in periprocedural stroke are available to date. Based on a selective literature review and own preliminary work, this review article aims to provide recommendations on the prevention and acute treatment of periprocedural stroke.
Indexed as
Identifiers
41842979What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.